原发性前列腺癌中 PSMA 免疫组化评分系统与参数 [18F]PSMA-1007 PET/MRI 的比较

IF 8.6 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING European Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2024-09-13 DOI:10.1007/s00259-024-06903-7
Niloefar Ahmadi Bidakhvidi, Thomas Gevaert, Maxim De Schepper, Marcella Baldewijns, Enrique Havinga, Wies Deckers, Annouschka Laenen, Gaëtan Devos, Alexander Giesen, Steven Joniau, Michel Koole, Wouter Everaerts, Christophe M. Deroose, Karolien Goffin
{"title":"原发性前列腺癌中 PSMA 免疫组化评分系统与参数 [18F]PSMA-1007 PET/MRI 的比较","authors":"Niloefar Ahmadi Bidakhvidi, Thomas Gevaert, Maxim De Schepper, Marcella Baldewijns, Enrique Havinga, Wies Deckers, Annouschka Laenen, Gaëtan Devos, Alexander Giesen, Steven Joniau, Michel Koole, Wouter Everaerts, Christophe M. Deroose, Karolien Goffin","doi":"10.1007/s00259-024-06903-7","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>Quantification of PSMA expression via PSMA PET is well-established, however quantification of PSMA via immunohistochemistry (IHC) is not standardized. Our aim was to determine the most optimal PSMA IHC scoring system to quantify PSMA expression with PSMA PET as reference standard.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Primary intermediate- and high-risk prostate cancer patients received an [<sup>18</sup>F]PSMA-1007 PET/MRI followed by radical prostatectomy. SUV<sub>max</sub>, SUV<sub>mean</sub> and K<sub>i</sub> of the prostate tumor was determined. Prostate tumors were stained with anti-PSMA antibodies and scored by 2 readers via 10 IHC scoring systems: histochemical score (H-score), immunoreactivity score<sub>predominant intensity</sub> (IRS<sub>predominant intensity</sub>), IRS classification<sub>predominant intensity</sub>, IRS<sub>mean intensity</sub>, IRS classification<sub>mean intensity</sub>, Allred score, predominant expression pattern, Shannon diversity index (SDI), percentage negatively stained cells and total percentage positively stained cells. Spearman’s rank correlation coefficients (ρ) were calculated between PET parameters and IHC scoring systems. Interreader agreement for the IHC scoring systems was measured by the intraclass correlation coefficient (ICC).</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Fifty tumors in 46 patients were analysed. H-score had the best correlation with SUV<sub>max</sub> (ρ 0.615 <i>p</i> &lt; 0.0001) and SUV<sub>mean</sub> (ρ 0.570, <i>p</i> &lt; 0.0001) and the second best correlation with K<sub>i</sub> (ρ 0.411, <i>p</i> = 0.0030). SDI had the best correlation with K<sub>i</sub> (ρ -0.440, <i>p</i> = 0.0014) and the second best correlation with SUV<sub>max</sub> (ρ -0.516, <i>p</i> = 0.0001) and SUV<sub>mean</sub> (ρ -0.490, <i>p</i> = 0.0003). A moderate interreader agreement was observed for H-score (ICC 0.663, 95% CI 0.495–0.797) and SDI (ICC 0.546, 95% CI 0.354–0.725).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>H-score had the best correlation with PSMA PET quantification and an acceptable interreader agreement. Therefore, we deem H-score the most optimal PSMA IHC scoring system.</p>","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":null,"pages":null},"PeriodicalIF":8.6000,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparison of PSMA immunohistochemistry scoring systems to parametric [18F]PSMA-1007 PET/MRI in primary prostate cancer\",\"authors\":\"Niloefar Ahmadi Bidakhvidi, Thomas Gevaert, Maxim De Schepper, Marcella Baldewijns, Enrique Havinga, Wies Deckers, Annouschka Laenen, Gaëtan Devos, Alexander Giesen, Steven Joniau, Michel Koole, Wouter Everaerts, Christophe M. Deroose, Karolien Goffin\",\"doi\":\"10.1007/s00259-024-06903-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<h3 data-test=\\\"abstract-sub-heading\\\">Purpose</h3><p>Quantification of PSMA expression via PSMA PET is well-established, however quantification of PSMA via immunohistochemistry (IHC) is not standardized. Our aim was to determine the most optimal PSMA IHC scoring system to quantify PSMA expression with PSMA PET as reference standard.</p><h3 data-test=\\\"abstract-sub-heading\\\">Methods</h3><p>Primary intermediate- and high-risk prostate cancer patients received an [<sup>18</sup>F]PSMA-1007 PET/MRI followed by radical prostatectomy. SUV<sub>max</sub>, SUV<sub>mean</sub> and K<sub>i</sub> of the prostate tumor was determined. Prostate tumors were stained with anti-PSMA antibodies and scored by 2 readers via 10 IHC scoring systems: histochemical score (H-score), immunoreactivity score<sub>predominant intensity</sub> (IRS<sub>predominant intensity</sub>), IRS classification<sub>predominant intensity</sub>, IRS<sub>mean intensity</sub>, IRS classification<sub>mean intensity</sub>, Allred score, predominant expression pattern, Shannon diversity index (SDI), percentage negatively stained cells and total percentage positively stained cells. Spearman’s rank correlation coefficients (ρ) were calculated between PET parameters and IHC scoring systems. Interreader agreement for the IHC scoring systems was measured by the intraclass correlation coefficient (ICC).</p><h3 data-test=\\\"abstract-sub-heading\\\">Results</h3><p>Fifty tumors in 46 patients were analysed. H-score had the best correlation with SUV<sub>max</sub> (ρ 0.615 <i>p</i> &lt; 0.0001) and SUV<sub>mean</sub> (ρ 0.570, <i>p</i> &lt; 0.0001) and the second best correlation with K<sub>i</sub> (ρ 0.411, <i>p</i> = 0.0030). SDI had the best correlation with K<sub>i</sub> (ρ -0.440, <i>p</i> = 0.0014) and the second best correlation with SUV<sub>max</sub> (ρ -0.516, <i>p</i> = 0.0001) and SUV<sub>mean</sub> (ρ -0.490, <i>p</i> = 0.0003). A moderate interreader agreement was observed for H-score (ICC 0.663, 95% CI 0.495–0.797) and SDI (ICC 0.546, 95% CI 0.354–0.725).</p><h3 data-test=\\\"abstract-sub-heading\\\">Conclusion</h3><p>H-score had the best correlation with PSMA PET quantification and an acceptable interreader agreement. Therefore, we deem H-score the most optimal PSMA IHC scoring system.</p>\",\"PeriodicalId\":11909,\"journal\":{\"name\":\"European Journal of Nuclear Medicine and Molecular Imaging\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":8.6000,\"publicationDate\":\"2024-09-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Nuclear Medicine and Molecular Imaging\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00259-024-06903-7\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Nuclear Medicine and Molecular Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00259-024-06903-7","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

摘要

目的通过 PSMA PET 定量 PSMA 的表达已得到广泛认可,但通过免疫组化 (IHC) 定量 PSMA 的方法尚未标准化。我们的目的是确定以 PSMA PET 为参考标准量化 PSMA 表达的最佳 PSMA IHC 评分系统。测定前列腺肿瘤的 SUVmax、SUVmean 和 Ki。用抗 PSMA 抗体对前列腺肿瘤进行染色,并由两名阅读者通过 10 种 IHC 评分系统进行评分:组织化学评分(H-score)、免疫反应评分优势强度(IRSpredominant intensity,IRS 优势强度)、IRS 分类优势强度、IRS 平均强度、IRS 分类平均强度、Allred 评分、优势表达模式、香农多样性指数(SDI)、阴性染色细胞百分比和阳性染色细胞总百分比。计算了 PET 参数与 IHC 评分系统之间的斯皮尔曼等级相关系数 (ρ)。通过类内相关系数(ICC)测量 IHC 评分系统的读片者间一致性。H-score与SUVmax(ρ 0.615 p < 0.0001)和SUVmean(ρ 0.570, p < 0.0001)的相关性最好,与Ki的相关性次之(ρ 0.411, p = 0.0030)。SDI 与 Ki 的相关性最好(ρ -0.440,p = 0.0014),与 SUVmax 的相关性次之(ρ -0.516,p = 0.0001),与 SUVmean 的相关性最好(ρ -0.490,p = 0.0003)。H-score (ICC 0.663, 95% CI 0.495-0.797)和 SDI (ICC 0.546, 95% CI 0.354-0.725)的读片者间一致性为中等。因此,我们认为 H 评分是最理想的 PSMA IHC 评分系统。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Comparison of PSMA immunohistochemistry scoring systems to parametric [18F]PSMA-1007 PET/MRI in primary prostate cancer

Purpose

Quantification of PSMA expression via PSMA PET is well-established, however quantification of PSMA via immunohistochemistry (IHC) is not standardized. Our aim was to determine the most optimal PSMA IHC scoring system to quantify PSMA expression with PSMA PET as reference standard.

Methods

Primary intermediate- and high-risk prostate cancer patients received an [18F]PSMA-1007 PET/MRI followed by radical prostatectomy. SUVmax, SUVmean and Ki of the prostate tumor was determined. Prostate tumors were stained with anti-PSMA antibodies and scored by 2 readers via 10 IHC scoring systems: histochemical score (H-score), immunoreactivity scorepredominant intensity (IRSpredominant intensity), IRS classificationpredominant intensity, IRSmean intensity, IRS classificationmean intensity, Allred score, predominant expression pattern, Shannon diversity index (SDI), percentage negatively stained cells and total percentage positively stained cells. Spearman’s rank correlation coefficients (ρ) were calculated between PET parameters and IHC scoring systems. Interreader agreement for the IHC scoring systems was measured by the intraclass correlation coefficient (ICC).

Results

Fifty tumors in 46 patients were analysed. H-score had the best correlation with SUVmax (ρ 0.615 p < 0.0001) and SUVmean (ρ 0.570, p < 0.0001) and the second best correlation with Ki (ρ 0.411, p = 0.0030). SDI had the best correlation with Ki (ρ -0.440, p = 0.0014) and the second best correlation with SUVmax (ρ -0.516, p = 0.0001) and SUVmean (ρ -0.490, p = 0.0003). A moderate interreader agreement was observed for H-score (ICC 0.663, 95% CI 0.495–0.797) and SDI (ICC 0.546, 95% CI 0.354–0.725).

Conclusion

H-score had the best correlation with PSMA PET quantification and an acceptable interreader agreement. Therefore, we deem H-score the most optimal PSMA IHC scoring system.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
15.60
自引率
9.90%
发文量
392
审稿时长
3 months
期刊介绍: The European Journal of Nuclear Medicine and Molecular Imaging serves as a platform for the exchange of clinical and scientific information within nuclear medicine and related professions. It welcomes international submissions from professionals involved in the functional, metabolic, and molecular investigation of diseases. The journal's coverage spans physics, dosimetry, radiation biology, radiochemistry, and pharmacy, providing high-quality peer review by experts in the field. Known for highly cited and downloaded articles, it ensures global visibility for research work and is part of the EJNMMI journal family.
期刊最新文献
Quantitative aortic Na[18F]F positron emission tomography computed tomography as a tool to associate vascular calcification with major adverse cardiovascular events Development and characterisation of [18F]TTDP, a novel T cell immunoglobulin and ITIM domain tracer, in humanised mice and non-human primates Development of STING probes and visualization of STING in multiple tumor types Survival impact of [225Ac]Ac-DOTATOC alpha-therapy in a preclinical model of pancreatic neuroendocrine tumor liver micrometastases Comparison of PSMA immunohistochemistry scoring systems to parametric [18F]PSMA-1007 PET/MRI in primary prostate cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1